151 related articles for article (PubMed ID: 10464316)
21. Identification and characterization of a binding site for platelets in the Apple 3 domain of coagulation factor XI.
Baglia FA; Jameson BA; Walsh PN
J Biol Chem; 1995 Mar; 270(12):6734-40. PubMed ID: 7896818
[TBL] [Abstract][Full Text] [Related]
22. Factor XI apple domains and protein dimerization.
Cheng Q; Sun MF; Kravtsov DV; Aktimur A; Gailani D
J Thromb Haemost; 2003 Nov; 1(11):2340-7. PubMed ID: 14629467
[TBL] [Abstract][Full Text] [Related]
23. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
[TBL] [Abstract][Full Text] [Related]
24. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
[No Abstract] [Full Text] [Related]
25. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
Olson ST; Francis AM; Sheffer R; Choay J
Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
[TBL] [Abstract][Full Text] [Related]
26. Plasma kallikrein structure reveals apple domain disc rotated conformation compared to factor XI.
Li C; Voos KM; Pathak M; Hall G; McCrae KR; Dreveny I; Li R; Emsley J
J Thromb Haemost; 2019 May; 17(5):759-770. PubMed ID: 30801944
[TBL] [Abstract][Full Text] [Related]
27. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
Page JD; Colman RW
J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
[TBL] [Abstract][Full Text] [Related]
28. The bradykinin-forming cascade: a historical perspective.
Kaplan AP
Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
[TBL] [Abstract][Full Text] [Related]
29. Skeletal muscle myosin promotes coagulation by binding factor XI via its A3 domain and enhancing thrombin-induced factor XI activation.
Morla S; Deguchi H; Zilberman-Rudenko J; Gruber A; McCarty OJT; Srivastava P; Gailani D; Griffin JH
J Biol Chem; 2022 Feb; 298(2):101567. PubMed ID: 35007530
[TBL] [Abstract][Full Text] [Related]
30. Physiologic activities of the contact activation system.
Schmaier AH
Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.
Herwald H; Dedio J; Kellner R; Loos M; Müller-Esterl W
J Biol Chem; 1996 May; 271(22):13040-7. PubMed ID: 8662673
[TBL] [Abstract][Full Text] [Related]
32. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093
[TBL] [Abstract][Full Text] [Related]
33. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.
Nakazawa Y; Joseph K; Kaplan AP
Int Immunopharmacol; 2002 Dec; 2(13-14):1875-85. PubMed ID: 12494915
[TBL] [Abstract][Full Text] [Related]
35. The involvement of proteoglycans in the human plasma prekallikrein interaction with the cell surface.
Veronez CL; Nascimento FD; Melo KR; Nader HB; Tersariol IL; Motta G
PLoS One; 2014; 9(3):e91280. PubMed ID: 24621563
[TBL] [Abstract][Full Text] [Related]
36. Identification of a binding site for glycoprotein Ibalpha in the Apple 3 domain of factor XI.
Baglia FA; Gailani D; López JA; Walsh PN
J Biol Chem; 2004 Oct; 279(44):45470-6. PubMed ID: 15317813
[TBL] [Abstract][Full Text] [Related]
37. Factor XI, but not prekallikrein, blocks high molecular weight kininogen binding to human umbilical vein endothelial cells.
Baird TR; Walsh PN
J Biol Chem; 2003 Jun; 278(23):20618-23. PubMed ID: 12663668
[TBL] [Abstract][Full Text] [Related]
38. Immunovisualisation of plasma prekallikrein and H-kininogen on human neutrophils and in human hepatocytes.
Henderson LM; Figueroa CD; Muller-Esterl W; Stain A; Bhoola KD
Agents Actions Suppl; 1992; 38 ( Pt 1)():590-4. PubMed ID: 1466300
[TBL] [Abstract][Full Text] [Related]
39. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
Kaplan AP; Joseph K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
[TBL] [Abstract][Full Text] [Related]
40. Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo.
Chen ZL; Singh PK; Horn K; Calvano MR; Kaneki S; McCrae KR; Strickland S; Norris EH
Blood Adv; 2023 Apr; 7(7):1156-1167. PubMed ID: 36409609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
